Opinion
Selling US Grown Flower to Europe: What the Margin Actually Says
Written by Michael Sassano, Founder and Interim CEO, SOMAÍ Pharmaceuticals Most US cannabis companies thinking about Europe focus on the wrong number.
Michael Sassano
5stories
12 Auglast updated
More in Michael Sassano
- Opinion
With Extracts Expected To Achieve A ‘50% Share Of The EU Cannabis Market’ In The Next Few Years, Who Is Currently Leading The Field?
Michael Sassano, CEO of international cannabis manufacturer Somai Pharmaceuticals, explores the state of cannabis extract manufacturing in Europe and who is currently leading the pack.
